28Feb 2017

RISK REDUCTION MASTECTOMY A NEW STRATEGY FOR PRIMARY AND SECONDARY PREVENTION OF BREAST CANCER– A LITERATURE REVIEW.

  • Department of Surgery Breast and Endocrine Unit, King Salman Armed Force Hospital KSAFH, Tabuk.
  • Prince Sultan Oncology Center, KSAFH, Tabuk.
Crossref Cited-by Linking logo
  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Background: In the last decade there has been a marked increase in the number of women requiring risk reduction mastectomy either before the development of breast cancer in high risk population or following the diagnosis of unilateral breast cancer. The breast surgeon and the oncologist are usually faced with difficult questions regarding the impact and the outcome of the various strategies that are used for risk reduction. This includes prophylactic mastectomy, close surveillance programs or chemoprevention. The outcome of these strategies and their effects on disease relapse and survival particularly prophylactic mastectomy either bilateral risk reduction mastectomy (brrm) for primary prevention or contralateral risk reduction mastectomy (crrm) for secondary prevention remains challenging and an area of great interest. Methods and data sources: a narrative literature review was performed using the available electronic database. This was intended to assess the available tools for risk assessment in addition to the impact of prophylactic mastectomy (bilateral in high risk individuals or contra-lateral in unilateral breast cancer patients) on the following: 1. Breast cancer risk reduction & outcome. 2. Decision making process in women at a high risk for bilateral or contralateral breast cancer. 3. Patients satisfaction and psychological status after surgery. Conclusion: Risk reduction prophylactic mastectomy in the form of bilateral or contralateral mastectomy is considered one useful strategy in patients at a high risk of breast cancer or with patients with unilateral breast cancer respectively. This strategy is recommended in some national and international guidelines.


  1. Wood SJE: Subcutaneous mastectomy: Current Stae of the art. Ann Plast Surg 11:541-550, 1983
  2. National Comprehensive Cancer Network. Breast Cancer Risk Reduction. V.2. 2015. http://www.nccn.org/professionals/physician_gls/pdf/breast_risk.pdf. Accessed July 13, 2015.
  3. Sakorafa S GH, tsiotou AG: Prophylatic mastectomy; evolving perspectives. Eur J Cancer 36 (5): 567-578, 2000.
  4. Yao K, Winchester DJ, Czechura T, et al. Contralateral prophylactic mastectomy and survival: report from the National Cancer Data Base, 1998-2002. Breast Cancer Res Treat. Dec 2013;142(3):465-476. PMID 24218052.
  5. Oppong BA, King TA. Recommendations for women with lobular carcinoma in situ (LCIS). Oncology (Williston Park). Oct 2011;25(11):1051-1056, 1058. PMID 22106556
  6. Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Shairer C, Mulylll JJ. Projecting individualized probabilities of developing breast cancer for white female who are being examined annually. J Natl Cancer Inst. 81 (24): 1879-86. 1989
  7. Matsuno RK, Costantino JP, Ziegler RG, Anderson GL, Li H, Pee D., and Gail MG. Projecting Individualized Absolute Invasive Breast Cancer Risk in Asian and Pacific Islander American Women J Natl Cancer Inst 2011
  8. National Cancer Institute. Breast Cancer Risk Assessment Tool. http://www.cancer.gov/bcrisktool/default. aspx, 2011.
 
  1. Elmore JG, Risk Prediction models for breast cancer screening. In: up-to-date. Hayes DF, Sokol HN (eds.) Walthan MA: Up to date 2015
 
  1. Yang XR, Chang-Claude J, good EL, et al. Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies. J Natl Cancer inst. 103 (3) 250-63, 2011
  2. Bilimoria MM, Morrow M. The woman at increased risk for breast cancer: evaluation and management strategies. CA Cancer J Clin. 45(5):263-278, 1995
  3. Bloodgood JC: The remaining breast after radical removal of the opposite side for carcinoma. Trans Southern Surg Assoc 34: 223-241, 1991
  4. Zeigler LD, Kroll SS: Primary breast cancer after prophylactic mastectomy. Ann J Clin Oncol 14: 451-454, 1991
  5. Eldars, Meguide MM, Beatty JD. Cancer of the breast after prophylactic subcutaneous mastectomy. Ann J Surgery 148: 692-693, 1984
  6. Lostumbo L, Carbine NE, Wallace J. Prophylactic mastectomy for the prevention of breast cancer. Cochrane Database Syst Rev. 2010 Nov 10;(11):CD002748 PMID: 21069671
  7. Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. Mar-Apr 2007;57(2):75-89. PMID 17392385
  8. Nichols HB, Berrington de Gonzalez A, Lacey JV, Jr., et al. Declining incidence of contralateral breast cancer in the United States from 1975 to 2006. J Clin Oncol. Apr 20 2011;29(12):1564-1569. PMID 21402610
  9. Molina-Montes E, Perez-Nevot B, Pollan M, et al. Cumulative risk of second primary contralateral breast cancer in BRCA1/BRCA2 mutation carriers with a first breast cancer: A systematic review and metaanalysis. Breast. Dec 2014;23(6):721-742. PMID 25467311
  10. Gabriel S, Wood JE, O'Fallon MW,et al. Complication leading to surgery of the breast implantation. N Engl J Med. 336:677-682, 1997
  11. Zion SM, Slezak JM, Schaid DJ, et al. Surgical morbidities following bilateral prophylactic mastectomy (Abstrat 1730) Proc Am Soc clin Oncol 19: 4419, 2000.
  12. Silva AK, Lapin B, Yao KA, et al. The effect of contralateral prophylactic mastectomy on perioperative complications in women undergoing immediate breast reconstruction: a NSQIP analysis. Ann Surg Oncol. Oct 2015;22(11):3474-3480. PMID 26001862
  13. Miller ME, Czechura T, Martz B, et al. Operative risks associated with contralateral prophylactic mastectomy: a single institution experience. Ann Surg Oncol. Dec 2013;20(13):4113-4120. PMID 23868655
  14. Frost MH, Schaid DJ, Sellers TA, et al: Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy. JAMA 284 (3):319-324. 200
  15. Hopwood P, Keeling F, Long A, Pool C et al. Psychological support needs for women at high genetic risk of breast cancer: some preliminary indicators. Psych Oncology 1998; 7:402-12.
  16. Hatcher MB, Fallowfield L, A Hern R: The psychosocial impact of bilateral prophylactic mastectomy: Prospective study using questionnaires and semistructured interviews. BMJ 322 (7278):76, 2011.
  17. Hartman LC, Schaid DJ, Woods JE, et al: Efficiency of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med 340(2):77-81, 1999.
  18. Maijers-Haijboer H, van Geel B, vam Putten Wl, et al: Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 and BRCA2 mutation. N Engl J med 345(3):159-164, 2001.
  19. Fayanju OM, Stoll CR, Fowler S, et al. Contralateral prophylactic mastectomy after unilateral breast cancer: a systematic review and meta-analysis. Ann Surg. Dec 2014;260(6):1000-1010. PMID 24950272
  20. Kruper L, Kauffmann RM, Smith DD, et al. Survival analysis of contralateral prophylactic mastectomy: a question of selection bias. Ann Surg Oncol. Oct 2014;21(11):3448-3456. PMID 25047478
  21. Pesce C, Liederbach E, Wang C, et al. Contralateral prophylactic mastectomy provides no survival benefit in young women with estrogen receptor-negative breast cancer. Ann Surg Oncol. Oct 2014;21(10):3231-3239. PMID 25081341
  22. Eisen A, Rebbeck TR, Wood WC, et al: Prophylactic surgery in women with a hereditary predisposition to breast and ovarian cancer. J Clin Oncol 18(9):1980-1995, 2000.
  23. National Comprehensive Cancer Network. Breast Cancer. V.2. 2015. http://www.nccn.org/professionals/physician_gls/pdf/breast.pdf. Accessed July 13, 2015.
  24. Giuliano AE, Boolbol S, Degnim A, et al. Society of Surgical Oncology: position statement on prophylactic mastectomy. Approved by the Society of Surgical Oncology Executive Council, March 2007. Ann Surg Oncol. Sep 2007;14(9):2425-2427. PMID 17597344
  25. National Cancer Institute. Fact Sheet: Surgery to Reduce the Risk of Breast Cancer. 2012, reviewed in 2013; http://www.cancer.gov/cancertopics/factsheet/Therapy/risk-reducing-surgery. Accessed April 6, 2016.

[Attiya bin Mohammad Al Zahrani, Youssef Al Alawi, Nihal Tarmanini and Mostafa Abdelrahman. (2017); RISK REDUCTION MASTECTOMY A NEW STRATEGY FOR PRIMARY AND SECONDARY PREVENTION OF BREAST CANCER– A LITERATURE REVIEW. Int. J. of Adv. Res. 5 (Feb). 2617-2626] (ISSN 2320-5407). www.journalijar.com


Dr. MIR RASHID
Consultant Clinical Oncologist, Prince Sultan Oncology Center, KSAFH, Tabuk

DOI:


Article DOI: 10.21474/IJAR01/3466      
DOI URL: http://dx.doi.org/10.21474/IJAR01/3466